Surgery & Anesthesiology
ScienceDaily (Dec. 3, 2012) A study reported here at the 66th American Epilepsy Society Annual Meeting has identified a significant difference in the brain response to stress in patients who believe stress is an important factor in their seizure control compared to patients who do not hold this belief. Many epilepsy patients believe that stress is a factor in their seizure control, while many other epilepsy patients do not have this perception
ScienceDaily (Dec. 3, 2012) A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. Data collected since the PED was approved for marketing show generally good results in “real world” clinical practice.
ScienceDaily (Nov. 30, 2012) Researchers at the University of California, San Diego School of Medicine and the VA San Diego Healthcare System have found that deficiencies in the neural processing of simple auditory tones can evolve into a cascade of dysfunctional information processing across wide swaths of the brain in patients with schizophrenia. The findings are published in the current online edition of the journal Neuroimage .
ScienceDaily (Nov. 29, 2012) Using standard tools of the molecular-biology trade and a new, much-improved animal model of a prevalent but poorly understood tropical parasitic disease called urogenital schistosomiasis, Stanford University School of Medicine researchers were able to obtain “snapshots” of shifting gene activity levels during the early, acute phase of what for most becomes a chronic bladder infection.
ScienceDaily (Nov. 29, 2012) Treating Parkinson’s disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson University researchers report in a new study published online November 28 in the Journal of the Neurological Sciences . Although the precise mechanisms of action of this drug are still unclear, the drug may protect patients’ dopamine-producing neurons from dying and at least partially restore their function, thereby increasing levels of dopamine, the key neurochemical missing in the brain of Parkinson’s patients
ScienceDaily (Nov. 29, 2012) Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS) — a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord. This discovery offers new hope for the millions who suffer from this debilitating disease for which there is no cure.
ScienceDaily (Nov. 28, 2012) A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology. The drug, suvorexant, blocks the chemical messengers in the brain called orexins, which regulate wakefulness.
ScienceDaily (Nov. 27, 2012) A new method of growing cardiac tissue is teaching old stem cells new tricks.
ScienceDaily (Nov. 27, 2012) Researchers at Boston University and the Association of American Medical Colleges (AAMC) have determined that heavily indebted medical students choosing primary care careers will experience difficulty paying their student debt unless they consider alternative strategies to support repayment. These findings appear online in Academic Medicine , the peer-reviewed Journal of the AAMC